ConnectMed
An African digital health startup that offered telehealth apps, kiosks, & chronic disease therapeutics - started in my MSc CompSci & ended in Merck KGaA asset sale
Role
Co-Founder & CEO / CPO
Industry
Health
Duration
3 years
Stage 3. Telehealth Kiosks in Pharmacy
Piloting the kiosk model: One of our flyer pharmacies (in the Sarit Center in Nairobi) owned by some entrepreneurial Kenyan Indians called us a few times and asked - "Hey, can this patient see the doctor now? Then we can make sure he gets the right diagnosis and I get the prescription needed to dispense the meds." It became clear the pharmacy is a great place to find & convert patients and pharmacies could be incentivized to offer this. I spent a week sitting in this pharmacy with a tablet and having one of our doctors on call and we got more patients than we had in the past 2 months.
Launching the pharmacy kiosks: At this point, it had been me and a right hand ops man (Dismus Masheti) doing everything and I needed some further funding & to find a cofounder that could help carry the load. I decided to join Entrepreneur First in London where I found Chris Harding, an ex-Palantir engineer who was ready to go on this journey with me. We worked on developing the kiosk, which was basically just an Android tablet (with our Android app we had now built) and a set of testing devices (eg blood pressure cuff, glucometer) with some professional signage.
Getting pharmacy kiosks to perform: We tried working with over 40 pharmacies across the greater Nairobi area, spanning income levels (expat-filled Karen to largest slum in Africa Kibera), commercial settings (shopping malls, downtown commerce, suburb commerce centers), pharmacy types (chains, mom-and-pop). We also tried several different conversion strategies (more professional looking kiosk constructs, offering referral rewards to the pharmacy staff, manning the pharmacies with our own sales people). Success came down to the below factors and we found most of our customers were middle income who liked the affordability (we had now reduced our price to less than local options) and convenience (and many had a chronic condition, foreshadowing the next section):
Staff Incentives: For pharmacies where the owner isn't the one manning the store, the consults seemed like a distraction to the pharmacy techs; it was only in some small pharmacies where the owner is the staff did they realize that the consults could actually help their business overall (eg with Waroko Pharmacy in Kangemi, the owner Ormarice realized her customers would buy their diabetes meds more consistently if they had the consults where a doctor was telling them what to take / titrating). Watch the great news feature on our kiosks that features this case :)
Foot traffic: Having high foot-traffic (basically top of funnel) was critical to getting a reasonable number of consults per day, especially to make our more expensive conversion strategies (ie having sales folks sitting there) work. So our other top performers were high traffic pharmacies in Nairobi CBD where it made sense to put a sales person.
Stage 4. Chronic Disease Digital Therapeutics
Seeing the need with chronic diseases: While we saw patients with a variety of conditions at our kiosks, there was a high prevalence of those with hypertension of diabetes. These patients really needed help with getting the right prescription (there's a process of measuring and titrating meds that most never pursue) and our kiosks were a great solution. We also so the economics of our kiosks were barely break even and we thought offering a higher value+revenue service to these chronic disease patients would be a more fruitful path, where we not only provide the consults but also the medications.
Launching the chronic disease therapeutics product: So we decided to flesh out a program with the consults, meds, testing device and a health coach, which included developing a consumer Android app as well as medication pickup partners. Because we wanted to capture the margin of giving the meds, we had to look for acquisition strategies that didn't depend on pharmacies and saw health screening activations were great (we would offer a free screening and then pitch appropriate patients on the program). The key was to do these in high foot traffic areas so we ended up getting approval to do these in Nairobi CBD (highest footraffic in the country). The economics seemed to be working and we had a patient subscription roster of 500 within a month and they were engaged (eg one of our patient education day).
Struggling with retention of patients: While patients engaged and we introduced the health coach component to both provide more value to the patient and ensure high touch+trust to keep the user subscribed, we saw 50% of patients churning by Month 3. At this point, they felt their meds were well titrated and getting the meds from us our pickup points was less convenient than their local pharmacy. They valued the testing device (which they could use an only owned after 6 months in the program) but they felt they already owned this (either they didn't understand it was a lease or in many cases, they just felt there was no way we'd get it back from them).
Stage 5. Deciding to Close & Sell
To make this an impactful, growing business, we'd need to move into brick & mortar clinics: The economics of the therapeutics product out best and I felt like we were really solving a strong need here but unless we could provide and capture more value, it wouldn't be a strong enough business. Primary care provision in most markets is not a very profitable enterprise and providers make their money on secondary & tertiary care, while the primary care acts as a feeder for this. So it seemed clear to me that to make this the kind of impactful, high growth startup I wanted to build, we'd need to offer these kinds of services and leverage our telehealth offering for lead gen and cost reduction. With other social enterprises in the market already doing this well (eg Penda Health) and me being rather burnt out at this point having pushed too hard during the past 2 years, Chris and I both decided it was best to close shop. We had just gotten a check from a local investor as well but knew this was the right call.
Finding a buyer for our assets: We had built valuable tech, clinical expertise, and more and I reached out to different partners we had worked with and other healthcare providers to see who might be interested. Merck KGaA ran a set of tech-forward pharmacies, under the brand Curafa, in Nairobi and we had setup a kiosk at 1 of them. They gave the best offer for our full package of assets and we completed the sale at start of 2019. Some news posts: Disrupt Africa, Startup Graveyard.
Other projects
Nova
Building a new, more efficient credit card payments network, leveraging open finance
Google Pay API
Making online checkouts better, by me growing usage of Google Pay API & adding new forms of payment like BNPL & e-wallets
Google Pay Africa
A new Google consumer payments app, bringing trust to Sub-Saharan African commerce & relevance for Google, that I got 35 headcount & $10M to build
Files by Google
The leading Android file & storage manager that I led from 100M to 250M MAUs, including getting it preinstalled on Google Pixel & taking over DocumentsUI
Google Maps Enterprise
Google Maps for transport & logistics companies, where I owned the Driver Experience product suite, including Google's Navigation SDK